PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 25 filers reported holding PSYCHEMEDICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $95,000 | +23.4% | 11,275 | +2.4% | 0.00% | – |
| Q2 2021 | $77,000 | +13.2% | 11,015 | -0.0% | 0.00% | – |
| Q1 2021 | $68,000 | -4.2% | 11,017 | -21.5% | 0.00% | – |
| Q4 2020 | $71,000 | -12.3% | 14,038 | -23.8% | 0.00% | – |
| Q3 2020 | $81,000 | -20.6% | 18,420 | 0.0% | 0.00% | – |
| Q2 2020 | $102,000 | -8.9% | 18,420 | -0.6% | 0.00% | – |
| Q1 2020 | $112,000 | -38.8% | 18,522 | -7.6% | 0.00% | – |
| Q4 2019 | $183,000 | -13.7% | 20,048 | -13.8% | 0.00% | – |
| Q3 2019 | $212,000 | -2.3% | 23,248 | +7.9% | 0.00% | – |
| Q2 2019 | $217,000 | -30.9% | 21,548 | -3.8% | 0.00% | -100.0% |
| Q1 2019 | $314,000 | -11.8% | 22,405 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $356,000 | -15.4% | 22,405 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $421,000 | -3.4% | 22,405 | -1.2% | 0.00% | 0.0% |
| Q2 2018 | $436,000 | -9.9% | 22,670 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $484,000 | +3.2% | 22,670 | -0.7% | 0.00% | 0.0% |
| Q4 2017 | $469,000 | – | 22,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 40,001 | $276,000 | 0.13% |
| SANTA MONICA PARTNERS LP | 20,000 | $138,000 | 0.10% |
| Invenomic Capital Management LP | 135,631 | $769,000 | 0.08% |
| Cannell Capital | 78,306 | $540,000 | 0.08% |
| RBF Capital, LLC | 144,231 | $996,000 | 0.06% |
| CRAWFORD INVESTMENT COUNSEL INC | 266,502 | $1,839,000 | 0.04% |
| Ancora Advisors LLC | 80,728 | $557,000 | 0.01% |
| HighMark Wealth Management LLC | 2,039 | $14,000 | 0.01% |
| Renaissance Technologies | 341,422 | $2,356,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 34,618 | $240,000 | 0.00% |